93 related articles for article (PubMed ID: 3045106)
1. Pharmacological effects of serotonin reuptake inhibitors.
Leonard BE
J Clin Psychiatry; 1988 Aug; 49 Suppl():12-7. PubMed ID: 3045106
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic properties of serotonergic agents and antidepressant drugs.
Fuller RW
J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
[TBL] [Abstract][Full Text] [Related]
3. Antidepressants. Current concepts of mode of action.
Léonard BE
Encephale; 1991; 17 Spec No 1():127-31. PubMed ID: 1677887
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
5. Serotonin reuptake blockers in vitro and in vivo.
Fuller RW; Wong DT
J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):36S-43S. PubMed ID: 2828437
[TBL] [Abstract][Full Text] [Related]
6. Delayed pharmacological effects of antidepressants.
Frazer A; Benmansour S
Mol Psychiatry; 2002; 7 Suppl 1():S23-8. PubMed ID: 11986992
[TBL] [Abstract][Full Text] [Related]
7. Bupropion: a review of its mechanism of antidepressant activity.
Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
[TBL] [Abstract][Full Text] [Related]
8. Clinical effects of serotonin reuptake inhibitors in the treatment of depressive illness.
Burrows GD; McIntyre IM; Judd FK; Norman TR
J Clin Psychiatry; 1988 Aug; 49 Suppl():18-22. PubMed ID: 3045107
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
[TBL] [Abstract][Full Text] [Related]
10. [Biochemical aspects of depression (author's transl)].
Duchemin AM
Sem Hop; 1981 Apr 18-25; 57(15-16):745-50. PubMed ID: 6269184
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
O'Donnell JM; Marek GJ; Seiden LS
Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor.
Eisensamer B; Rammes G; Gimpl G; Shapa M; Ferrari U; Hapfelmeier G; Bondy B; Parsons C; Gilling K; Zieglgänsberger W; Holsboer F; Rupprecht R
Mol Psychiatry; 2003 Nov; 8(12):994-1007. PubMed ID: 14647397
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular mechanisms of antidepressant drugs.
Owens MJ
Depress Anxiety; 1996-1997; 4(4):153-9. PubMed ID: 9166647
[TBL] [Abstract][Full Text] [Related]
15. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
Peña S; Baccichet E; Urbina M; Carreira I; Lima L
Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
[TBL] [Abstract][Full Text] [Related]
16. Some effects of mianserine (ORG GB 94) on amine metabolism in the rat brain.
Leonard BE
Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):92-5. PubMed ID: 616924
[TBL] [Abstract][Full Text] [Related]
17. A common uptake system for serotonin and dopamine in human platelets.
Omenn GS; Smith LT
J Clin Invest; 1978 Aug; 62(2):235-40. PubMed ID: 670392
[TBL] [Abstract][Full Text] [Related]
18. Studies on the biochemical mode of action of EGYT-475, a new antidepressant.
Tekes K; Tóthfalusi L; Malomvölgyi B; Hermán F; Magyar K
Pol J Pharmacol Pharm; 1987; 39(2):203-11. PubMed ID: 2448760
[TBL] [Abstract][Full Text] [Related]
19. 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.
Micheli F; Cavanni P; Andreotti D; Arban R; Benedetti R; Bertani B; Bettati M; Bettelini L; Bonanomi G; Braggio S; Carletti R; Checchia A; Corsi M; Fazzolari E; Fontana S; Marchioro C; Merlo-Pich E; Negri M; Oliosi B; Ratti E; Read KD; Roscic M; Sartori I; Spada S; Tedesco G; Tarsi L; Terreni S; Visentini F; Zocchi A; Zonzini L; Di Fabio R
J Med Chem; 2010 Jul; 53(13):4989-5001. PubMed ID: 20527970
[TBL] [Abstract][Full Text] [Related]
20. The contribution of drug research to investigating the nature of endogenous depression.
Carlsson A
Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):2-10. PubMed ID: 10584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
